These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 16950806)
1. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Cantero G; Campanella C; Mateos S; Cortés F Mutagenesis; 2006 Sep; 21(5):321-5. PubMed ID: 16950806 [TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II. Cantero G; Pastor N; Mateos S; Campanella C; Cortés F Mutat Res; 2006 Jul; 599(1-2):160-6. PubMed ID: 16574165 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Snyder RD; Gillies PJ Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117 [TBL] [Abstract][Full Text] [Related]
4. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine. Ferguson LR; Whiteside G; Holdaway KM; Baguley BC Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870 [TBL] [Abstract][Full Text] [Related]
5. Cells lacking DNA topoisomerase II beta are resistant to genistein. López-Lazaro M; Willmore E; Austin CA J Nat Prod; 2007 May; 70(5):763-7. PubMed ID: 17411092 [TBL] [Abstract][Full Text] [Related]
6. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation. Pastor N; Cantero G; Campanella C; Cortés F Mutat Res; 2005 Apr; 582(1-2):11-9. PubMed ID: 15781205 [TBL] [Abstract][Full Text] [Related]
7. Toward a comprehensive model for induced endoreduplication. Cortés F; Mateos S; Pastor N; Domínguez I Life Sci; 2004 Nov; 76(2):121-35. PubMed ID: 15519359 [TBL] [Abstract][Full Text] [Related]
8. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells. Mateos S; Domínguez I; Pastor N; Cantero G; Cortés F Mutat Res; 2005 Oct; 578(1-2):33-42. PubMed ID: 16202795 [TBL] [Abstract][Full Text] [Related]
9. The mycotoxin ochratoxin A inhibits DNA topoisomerase II and induces polyploidy in cultured CHO cells. Cosimi S; Orta L; Mateos S; Cortés F Toxicol In Vitro; 2009 Sep; 23(6):1110-5. PubMed ID: 19490938 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II. Hasinoff BB; Wu X; Begleiter A; Guziec LJ; Guziec F; Giorgianni A; Yang S; Jiang Y; Yalowich JC Cancer Chemother Pharmacol; 2006 Jan; 57(2):221-33. PubMed ID: 16010589 [TBL] [Abstract][Full Text] [Related]
11. The free radical scavenging activity of four flavonoids determined by the comet assay. Horvathova K; Novotny L; Vachalkova A Neoplasma; 2003; 50(4):291-5. PubMed ID: 12937843 [TBL] [Abstract][Full Text] [Related]
12. Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity. Lanoue L; Green KK; Kwik-Uribe C; Keen CL Exp Biol Med (Maywood); 2010 Jan; 235(1):77-89. PubMed ID: 20404022 [TBL] [Abstract][Full Text] [Related]
13. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. López-Lázaro M; Willmore E; Austin CA Mutat Res; 2010 Feb; 696(1):41-7. PubMed ID: 20025993 [TBL] [Abstract][Full Text] [Related]
14. Tea flavanols inhibit cell growth and DNA topoisomerase II activity and induce endoreduplication in cultured Chinese hamster cells. Neukam K; Pastor N; Cortés F Mutat Res; 2008 Jun; 654(1):8-12. PubMed ID: 18541453 [TBL] [Abstract][Full Text] [Related]
15. Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin. Olaharski AJ; Mondrala ST; Eastmond DA Mutat Res; 2005 Apr; 582(1-2):79-86. PubMed ID: 15781213 [TBL] [Abstract][Full Text] [Related]
16. Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs. Meikle I; Cummings J; Macpherson JS; Smyth JF Anticancer Drug Des; 1995 Oct; 10(7):515-27. PubMed ID: 7495476 [TBL] [Abstract][Full Text] [Related]
17. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Romanová D; Vachálková A; Cipák L; Ovesná Z; Rauko P Neoplasma; 2001; 48(2):104-7. PubMed ID: 11478688 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA). Bridewell DJ; Finlay GJ; Baguley BC Anticancer Drug Des; 2001 Dec; 16(6):317-24. PubMed ID: 12375884 [TBL] [Abstract][Full Text] [Related]
19. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex. Constantinou AI; Husband A Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967 [TBL] [Abstract][Full Text] [Related]
20. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor. Hajji N; Mateos S; Pastor N; Domínguez I; Cortés F Mutat Res; 2005 May; 583(1):26-35. PubMed ID: 15866463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]